. Decreased association of HSP90 impairs endothelial nitric oxide synthase in fetal lambs with persistent pulmonary hypertension. Am J Physiol Heart Circ Physiol 285: H204-H211, 2003; 10.1152/ajpheart.00837. 2002.-Persistent pulmonary hypertension of newborn (PPHN) is associated with decreased nitric oxide (NO) release and impaired pulmonary vasodilation. We investigated the hypothesis that decreased association of heat shock protein 90 (HSP90) with endothelial NO synthase (eNOS) impairs NO release and vasodilation in PPHN. The responses to the NOS agonist ATP were investigated in fetal lambs with PPHN induced by prenatal ligation of ductus arteriosus, and in sham ligation controls. ATP caused dose-dependent vasodilation in control pulmonary resistance arteries, and this response was attenuated in PPHN vessels. The response of control pulmonary arteries to ATP was attenuated by N Gnitro-L-arginine methyl ester (L-NAME), a NOS antagonist, and geldanamycin, an inhibitor of HSP90-eNOS interaction. The attenuated response to ATP observed in PPHN was improved by pretreatment of vessels with L-NAME or 4,5-dihydroxy-1,3-benzene-disulfonate, a superoxide scavenger. Pulmonary arteries from PPHN lambs had decreased basal levels of HSP90 in association with eNOS. Association of HSP90 with eNOS and NO release increased in response to ATP in control pulmonary artery endothelial cells, but not in cells from PPHN lambs. Decreased HSP90-eNOS interactions may contribute to the impaired NO release and vasodilation observed in the ductal ligation model of PPHN. persistent pulmonary hypertension; ATP; newborn A RAPID AND SUSTAINED DECREASE in the pulmonary vascular resistance at birth facilitates initiation of gas exchange during postnatal life. Release of endothelium-derived nitric oxide (NO) in the pulmonary circulation plays a major role in this birth-related vasodilation (2, 34, 40). Failure of this adaptation results in persistent pulmonary hypertension of newborn (PPHN), a condition associated with decreased NO synthase (NOS) activity (5, 35, 41), expression (5, 35, 41), and impaired 38) in fetal pulmonary arteries. The mechanism(s) of impaired NOS activity and pulmonary vasodilation in PPHN remains unknown. Our laboratory's previous studies (15-18) demonstrated that the purine nucleotide ATP contributes to birth-related pulmonary vasodilation in fetal lambs. ATP causes pulmonary vasodilation in fetal lambs in part by stimulation of NO release (17). ATP stimulates NO release from cultured vascular endothelial cells (8,28). However, the mechanism of NOS activation by ATP and its alteration in PPHN remain unknown.Heat shock protein 90 (HSP90), a molecular chaperone, modulates the endothelial NOS (eNOS) activity (10, 12, 32) and balance of NO and superoxide (O 2 Ϫ ⅐) release from eNOS (30) in response to several physiological stimuli. However, the role of this constitutively expressed chaperone in mediating vasodilation in the fetal pulmonary arteries and its role in mediating the effects of ATP on eNOS is unknown. We propose...